These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31030373)

  • 1. Exosomes, metastases, and the miracle of cancer stem cell markers.
    Wang Z; Zöller M
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
    Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
    J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
    Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
    Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
    Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
    Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer stem cell markers and exosomes - the incentive push.
    Heiler S; Wang Z; Zöller M
    World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.
    Kyuno D; Bauer N; Schnölzer M; Provaznik J; Ryschich E; Hackert T; Zöller M
    Int J Biol Sci; 2019; 15(10):2224-2239. PubMed ID: 31592143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.
    Sun H; Rana S; Wang Z; Zhao K; Schnölzer M; Provaznik J; Hackert T; Lv Q; Zöller M
    J Oncol; 2019; 2019():3516973. PubMed ID: 31485223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 and EpCAM: cancer-initiating cell markers.
    Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
    Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes in Cancer Disease.
    Zöller M
    Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
    Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.
    Yue S; Mu W; Erb U; Zöller M
    Oncotarget; 2015 Feb; 6(4):2366-84. PubMed ID: 25544774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
    Mu W; Wang Z; Zöller M
    Front Oncol; 2019; 9():1359. PubMed ID: 31921628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsmart tumor exosomes to steal the cancer initiating cell its niche.
    Thuma F; Zöller M
    Semin Cancer Biol; 2014 Oct; 28():39-50. PubMed ID: 24631836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
    Massoumi RL; Hines OJ; Eibl G; King JC
    Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
    Wang H; Rana S; Giese N; Büchler MW; Zöller M
    Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine and human pancreatic tumor exosome recovery in mouse serum: Diagnostic and prognostic potential and target cell delivery.
    Erb U; Zhao K; Wang Z; Xiao L; Zöller M
    Cancer Lett; 2017 Sep; 403():1-12. PubMed ID: 28619525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
    Wang Z; Zhao K; Hackert T; Zöller M
    Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of exosomes in metastatic colorectal cancer.
    Lafitte M; Lecointre C; Roche S
    Am J Physiol Cell Physiol; 2019 Nov; 317(5):C869-C880. PubMed ID: 31291143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and potential of exosome analysis for early pancreatic cancer detection.
    Erb U; Zöller M
    Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.